Why IMU is a multi multi bagger, page-11590

I couldn't agree with you more. They must have a strategy and pathway to commercialisation, which of course includes following the science as, of course we know, trial success is what is required to get the Big Pharma wallets out. So why not share their strategy with shareholders. Of course timelines are going to be reliant on many things and therefore fluid, but we can at least understand what their plan is. Is that unreasonable to expect as shareholder? And don't tell me to be patient, I have been here for just over 7 years now, lucky to make my first purchase at 0.008. And will be staying here for the long-term, but would like a few more specifics on the strategy. I don't believe that is unjustified.